All Schrödinger offices worldwide will be closed for the week of August 17-21 as part of a company-wide initiative to rest and recharge. Please expect limited responses during this time. Scientific and Technical Support team members will be available to answer emergency support issues only.

Contact Us
Conference

Discovery on Target 2024

CalendarDate & Time
  • September 30th – October 3rd, 2024
LocationLocation
  • Boston, Massachusetts
Register

Schrödinger is excited to be participating in the Discovery on Target 2024 conference taking place on September 30th – October 3rd in Boston, Massachusetts. Join us for a poster by Shelby Ellery, Principal Scientist II at Schrödinger, titled “Discovery of first-in-class highly selective Wee2 inhibitors.” Stop by booth #523 to speak with Schrödinger scientists.

Speaker:
Shelby Ellery, Principal Scientist II, Schrödinger

Abstract:
Selective Wee2 kinase inhibitors could address the unmet need for non-hormonal contraception.
In this poster, we describe the identification and further optimization of potent and selective Wee2 inhibitors. Our orthosteric series was improved by using prospective FEP+. In collaboration with HitGen, a DEL screen identified potent allosteric inhibitors. The allosteric series show exquisite kinome selectivity and target engagement in ex vivo mouse oocyte assays.

Register